Expert advisory.
Defensible evidence.
Every engagement.
The Novida Principal
The person behind every engagement. Novida is built around one commitment: the expert who scopes your engagement is the expert who delivers it.
Over 15 years of senior leadership in RWE, HEOR, and clinical trial analytics across pharmaceutical research and global CRO environments. Led evidence generation across 12 or more products in immunology, rare diseases, and oncology. Distinctive ability to bridge clinical and scientific users with data science and technology teams, synthesizing fragmented data into defensible evidence frameworks and translating scientific requirements into systems that developers can build and regulators can trust. Epidemiology and Demography training directly informs Novida's approach to disease epidemiology synthesis, patient distribution, disease trajectory, and enrollment representativeness.
CREDENTIALS
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PUBLICATIONS
Published in Cancer, Annals of Rheumatic Diseases, and Journal of Health Economics and Outcomes Research.
COLLABORATOR NOTE
Collaborator network: Jay Visaria, PhD, MPH, HEOR researcher and leader with 15 or more years in payer-manufacturer collaboration, value-based contracting, and outcomes-based agreements. Engaged for commercial and market access intelligence projects.
The Novida Principal
The person behind every engagement. Novida is built around one commitment: the expert who scopes your engagement is the expert who delivers it.
Over 15 years of senior leadership in RWE, HEOR, and clinical trial analytics across pharmaceutical research and global CRO environments. Led evidence generation across 12 or more products in immunology, rare diseases, and oncology. Distinctive ability to bridge clinical and scientific users with data science and technology teams, synthesizing fragmented data into defensible evidence frameworks and translating scientific requirements into systems that developers can build and regulators can trust. Epidemiology and Demography training directly informs Novida's approach to disease epidemiology synthesis, patient distribution, disease trajectory, and enrollment representativeness.
CREDENTIALS
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PUBLICATIONS
Published in Cancer, Annals of Rheumatic Diseases, and Journal of Health Economics and Outcomes Research.
COLLABORATOR NOTE
Collaborator network: Jay Visaria, PhD, MPH, HEOR researcher and leader with 15 or more years in payer-manufacturer collaboration, value-based contracting, and outcomes-based agreements. Engaged for commercial and market access intelligence projects.
The Novida Principal
The person behind every engagement. Novida is built around one commitment: the expert who scopes your engagement is the expert who delivers it.
Over 15 years of senior leadership in RWE, HEOR, and clinical trial analytics across pharmaceutical research and global CRO environments. Led evidence generation across 12 or more products in immunology, rare diseases, and oncology. Distinctive ability to bridge clinical and scientific users with data science and technology teams, synthesizing fragmented data into defensible evidence frameworks and translating scientific requirements into systems that developers can build and regulators can trust. Epidemiology and Demography training directly informs Novida's approach to disease epidemiology synthesis, patient distribution, disease trajectory, and enrollment representativeness.
CREDENTIALS
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PhD Demography · Penn State
Health Policy and Administration
MPH
UAB
ISPOR
ISPE
ISCR
PUBLICATIONS
Published in Cancer, Annals of Rheumatic Diseases, and Journal of Health Economics and Outcomes Research.
COLLABORATOR NOTE
Collaborator network: Jay Visaria, PhD, MPH, HEOR researcher and leader with 15 or more years in payer-manufacturer collaboration, value-based contracting, and outcomes-based agreements. Engaged for commercial and market access intelligence projects.
Our Advisory Philosophy
Methodology-grounded. Synthesis-focused.
Every recommendation is traceable to evidence and methodology, not opinion.
Expert-led, methodology-grounded
Senior domain expertise in RWD, RWE, HEOR, Epidemiology, and Demography. Recommendations trace to evidence, not opinion.
Synthesis over silos.
Fragmented data, including publicly available and underutilized sources, synthesized into coherent, defensible evidence.
Vendor-agnostic.
No proprietary data network. No preferred platform. Recommendations reflect what is right for the client's specific question.
Built for scrutiny.
Outputs structured for regulatory submission, governance review, or HTA use from deliverable one. Ready to engage directly with regulatory and governance bodies.
How we Work
One model. Four modes.
Mode 1
Strategic
Advising on what to build, in what sequence, and why. Engaged at VP, CTO, CDO, CMO, or Head of Evidence Generation level.
Mode 2
Design
Defining the framework, methodology, and functional requirements for an evidence system or analytical tool.
Mode 3
Validation
Independent expert review confirming outputs are methodologically sound and defensible before regulatory or HTA scrutiny.
Mode 4
Translation
Bridging the gap between clinical and scientific users and technical builders throughout a project or system build.
Dr. Punekar works alongside your existing team. She provides domain expertise and synthesis methodology. Your team provides execution capacity.
How we Engage
A clear process. Every time.
Step 1
Scoping and Alignment.
Problem definition, deliverable specification, and timeline agreement. No work begins until the scope is agreed in writing.
Step 2
Framework and Methodology Design.
Analytical framework design, regulatory alignment, and documentation of approach.
Step 3
Advisory Delivery.
Evidence synthesis advisory, framework development, system requirement definition, or validation outputs. All outputs documented with rationale.
Step 4
Knowledge Transfer.
Output review, findings presentation, and full documentation handoff. Optional follow-on advisory.ng or improving evidence planning capabilities, with or without a technology layer.
Experts & Consultants
Senior specialists engaged on need. Every consultant in the network works exclusively in RWE, HEOR, biostatistics, or clinical analytics — selected for each engagement based on therapeutic area, methodology, and client context.
Rashmita Basu, PhD
Expert
Jay Visaria, PhD, MPH
Consultants
Our Advisory Philosophy
Methodology-grounded. Synthesis-focused.
Every recommendation is traceable to evidence and methodology, not opinion.
Expert-led, methodology-grounded
Senior domain expertise in RWD, RWE, HEOR, Epidemiology, and Demography. Recommendations trace to evidence, not opinion.
Synthesis over silos.
Fragmented data, including publicly available and underutilized sources, synthesized into coherent, defensible evidence.
Vendor-agnostic.
No proprietary data network. No preferred platform. Recommendations reflect what is right for the client's specific question.
Built for scrutiny.
Outputs structured for regulatory submission, governance review, or HTA use from deliverable one. Ready to engage directly with regulatory and governance bodies.
How we Work
One model. Four modes.
Mode 1
Strategic
Advising on what to build, in what sequence, and why. Engaged at VP, CTO, CDO, CMO, or Head of Evidence Generation level.
Mode 2
Design
Defining the framework, methodology, and functional requirements for an evidence system or analytical tool.
Mode 3
Validation
Independent expert review confirming outputs are methodologically sound and defensible before regulatory or HTA scrutiny.
Mode 4
Translation
Bridging the gap between clinical and scientific users and technical builders throughout a project or system build.
Dr. Punekar works alongside your existing team. She provides domain expertise and synthesis methodology. Your team provides execution capacity.
How we Engage
A clear process. Every time.
Step 1
Scoping and Alignment.
Problem definition, deliverable specification, and timeline agreement. No work begins until the scope is agreed in writing.
Step 2
Framework and Methodology Design.
Analytical framework design, regulatory alignment, and documentation of approach.
Step 3
Advisory Delivery.
Evidence synthesis advisory, framework development, system requirement definition, or validation outputs. All outputs documented with rationale.
Step 4
Knowledge Transfer.
Output review, findings presentation, and full documentation handoff. Optional follow-on advisory.ng or improving evidence planning capabilities, with or without a technology layer.
Experts & Consultants
Senior specialists engaged on need. Every consultant in the network works exclusively in RWE, HEOR, biostatistics, or clinical analytics — selected for each engagement based on therapeutic area, methodology, and client context.
Rashmita Basu, PhD
Expert
Jay Visaria, PhD, MPH
Consultants
Our Advisory Philosophy
Methodology-grounded. Synthesis-focused.
Every recommendation is traceable to evidence and methodology, not opinion.
Expert-led, methodology-grounded
Senior domain expertise in RWD, RWE, HEOR, Epidemiology, and Demography. Recommendations trace to evidence, not opinion.
Synthesis over silos.
Fragmented data, including publicly available and underutilized sources, synthesized into coherent, defensible evidence.
Transparent methodology
No proprietary data network. No preferred platform. Recommendations reflect what is right for the client's specific question.
Transparent methodology
Outputs structured for regulatory submission, governance review, or HTA use from deliverable one. Ready to engage directly with regulatory and governance bodies.
How we Work
One model. Four modes.
Mode 1
Strategic
Advising on what to build, in what sequence, and why. Engaged at VP, CTO, CDO, CMO, or Head of Evidence Generation level.
Mode 2
Design
Defining the framework, methodology, and functional requirements for an evidence system or analytical tool.
Mode 3
Validation
Independent expert review confirming outputs are methodologically sound and defensible before regulatory or HTA scrutiny.
Mode 4
Translation
Bridging the gap between clinical and scientific users and technical builders throughout a project or system build.
Dr. Punekar works alongside your existing team. She provides domain expertise and synthesis methodology. Your team provides execution capacity.
How we Engage
A clear process. Every time.
Step 1
Scoping and Alignment.
Problem definition, deliverable specification, and timeline agreement. No work begins until the scope is agreed in writing.
Step 2
Framework and Methodology Design.
Analytical framework design, regulatory alignment, and documentation of approach.
Step 3
Advisory Delivery.
Evidence synthesis advisory, framework development, system requirement definition, or validation outputs. All outputs documented with rationale.
Step 4
Knowledge Transfer.
Output review, findings presentation, and full documentation handoff. Optional follow-on advisory.ng or improving evidence planning capabilities, with or without a technology layer.
Experts & Consultants
Senior specialists engaged on need. Every consultant in the network works exclusively in RWE, HEOR, biostatistics, or clinical analytics — selected for each engagement based on therapeutic area, methodology, and client context.
Rashmita Basu, PhD
Expert
Jay Visaria, PhD, MPH
Consultants